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AbstrACt
Introduction The number of inconclusive physical 
rehabilitation randomised controlled trials for patients 
with critical illness is increasing. Evidence suggests 
critical illness patient subgroups may exist that benefit 
from targeted physical rehabilitation interventions that 
could improve their recovery trajectory. We aim to identify 
critical illness patient subgroups that respond to physical 
rehabilitation and map recovery trajectories according to 
physical function and quality of life outcomes. Additionally, 
the utilisation of healthcare resources will be examined for 
subgroups identified.
Methods and analysis This is an individual participant 
data meta- analysis protocol. A systematic literature 
review was conducted for randomised controlled trials 
that delivered additional physical rehabilitation for 
patients with critical illness during their acute hospital 
stay, assessed chronic disease burden, with a minimum 
follow- up period of 3 months measuring performance- 
based physical function and health- related quality of life 
outcomes. From 2178 records retrieved in the systematic 
literature review, four eligible trials were identified by two 
independent reviewers. Principal investigators of eligible 
trials were invited to contribute their data to this individual 
participant data meta- analysis. Risk of bias will be 
assessed (Cochrane risk of bias tool for randomised trials). 
Participant and trial characteristics, interventions and 
outcomes data of included studies will be summarised. 
Meta- analyses will entail a one- stage model, which will 
account for the heterogeneity across and the clustering 
between studies. Multiple imputation using chained 
equations will be used to account for the missing data.
Ethics and dissemination This individual participant 
data meta- analysis does not require ethical review as 
anonymised participant data will be used and no new 
data collected. Additionally, eligible trials were granted 
approval by institutional review boards or research 
ethics committees and informed consent was provided 
for participants. Data sharing agreements are in place 
permitting contribution of data. The study findings will be 
disseminated at conferences and through peer- reviewed 
publications.
PrOsPErO registration number CRD42019152526.
IntrOduCtIOn
The challenge facing many survivors of crit-
ical illness is disability, specifically, deficits 
in physical function that negatively impact 
quality of life and activities of daily living 
which can persist for several years.1–4 There 
is level one evidence that physical rehabil-
itation provided in the intensive care unit 
(ICU) is safe5 and reduces physical activity 
limitation at hospital discharge.6 However, 
large randomised controlled trials measuring 
long- term outcomes do not uniformly 
report sustained improvements in phys-
ical function or health- related quality of 
life (HRQoL).7–11 One of the factors poten-
tially contributing to these inconclusive trial 
strengths and limitations of this study
 ► According to our literature searches, this will be 
the first individual participant data meta- analysis to 
examine the response to physical rehabilitation in-
terventions and map recovery trajectories of patient 
subgroups with critical illness.
 ► Individual participant data meta- analyses provide 
greater statistical power than individual randomised 
controlled trials and more reliable subgroup anal-
yses than systematic reviews that use aggregate 
data.
 ► The subgroup analyses outlined will provide valuable 
information on effect modifiers of physical rehabili-
tation interventions for patients with critical illness.
 ► This work will also assist with future trial design 
by informing eligibility and stratification criteria to 
maximise statistical power and potentially reduce 
sample size.
 ► Additionally, the planned subgroup analyses will 
inform clinical practice and future research on the 
delivery of targeted physical rehabilitation interven-
tions for patients most likely to benefit, provided at 
the optimal time in their recovery.
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results is the heterogeneity of the critical ill populations 
studied whereby patient subgroups with unique trajec-
tories of recovery exist and may respond differently 
to physical rehabilitation interventions. Specifically, 
there is emerging evidence that patient characteristics, 
for example, chronic disease burden, are influential in 
recovery from critical illness3 12 13 and may modify the 
effect of physical rehabilitation interventions delivered.14
Exploration of the physical function and HRQoL 
recovery trajectories of critically ill patients enrolled in 
physical rehabilitation trials is limited.12 14 15 However, 
post hoc analyses of randomised controlled trials indi-
cate that patient characteristics including chronic disease 
burden,14 age and female sex15 are associated with long- 
term physical performance outcomes. Post hoc analyses 
of published randomised controlled trials12 14–16 also 
show that participant characteristics, specifically chronic 
disease burden,12 14 can alter the recovery trajectory of 
critically ill patients. Acute illness severity has been shown 
to predict HRQoL in critically ill patients,17 however, a 
recent post hoc analysis of a rehabilitation randomised 
controlled trial did not demonstrate an association 
between these variables.12 Given a single randomised 
controlled trial has limited statistical power to detect 
significant subgroup treatment effects, further investiga-
tion of patient subgroups is warranted.18
Individual participant data meta- analyses are consid-
ered the gold standard of systematic reviews19 20 enabling 
assessment of the interactions between interventions 
and patient characteristics with statistical power beyond 
a randomised controlled trial.21 Additionally, use of indi-
vidual participant data provides more reliable subgroup 
analysis results compared with systematic reviews that use 
aggregate level data, which rely on summary statistics.21 
Subgroup analyses will enable us to identify patient char-
acteristics that modify the association between physical 
rehabilitation interventions and the outcomes of critically 
ill patients. This will allow us to identify patient subgroups 
that will most benefit from the intervention.22 When iden-
tified, these patient characteristics could inform eligibility 
criteria of future randomised controlled trials and stratify 
participants enrolled, for example, according to chronic 
disease burden,14 to maximise statistical power23 and 
reduce sample size.24 Clarity on patient characteristics 
that are important in response to physical rehabilitation 
interventions may also assist in uncovering the mecha-
nism23 behind the debilitating effects of critical illness. 
Additionally, identification of these patient characteris-
tics could assist with unveiling differing phenotypes of 
critically ill patients and their rehabilitation needs. From 
this approach, the concept of personalised medicine 
could be applied to physical rehabilitation interventions 
for patients with critical illness.
Several systematic reviews and meta- analyses have been 
published that examine the effectiveness of physical reha-
bilitation for patients with critical illness6 25–27 however, 
none use individual participant data. Therefore, the aim 
of this systematic review and individual participant data 
meta- analysis is to identify subgroups of patients with 
critical illness that respond to physical rehabilitation 
and map their recovery trajectories according to physical 
function and HRQoL outcomes. The objectives are:
1. For each outcome of interest (physical function mea-
sured at hospital discharge, 3 and 6 months, and 
HRQoL measured at 3, 6 and 12 months), we will assess 
whether there is an interaction between the treatment 
group (intervention vs control) and each of the, a pri-
ori identified, participant characteristics (ie, chronic 
disease burden, sex, age group and acute illness sever-
ity) and the outcome.
2. For the following outcomes relating to utilisation of 
healthcare resources: mechanical ventilation duration 
(days), ICU length of stay (days), hospital length of 
stay (days) and discharge location (home, rehabilita-
tion facility, another hospital, skilled nursing or aged 
care facility, other), we will assess whether there is an 
interaction between the treatment group and each of 
the, a priori identified, participant characteristics (ie, 
chronic disease burden, sex, age group and acute ill-
ness severity).
MEthOds And AnAlysIs
This systematic review and individual participant data 
meta- analysis was registered a priori with the Interna-
tional Prospective Register of Systematic Reviews. Our 
PROSPERO registration (CRD42019152526) was lodged 
on 27 September 2019 (start date) and the anticipated 
study completion date is 31 December 2020. This study is 
also registered with research registry (reviewregistry759). 
Important protocol amendments will be documented 
with an accompanying explanation and be made publicly 
available on the registration record. Prior to registration, 
PROSPERO and the Cochrane Database of Systematic 
Reviews were searched to check no other similar system-
atic review and individual participant data meta- analysis 
was registered or undertaken. The individual partici-
pant data meta- analysis will be conducted according to 
the Cochrane Individual Participant Data Meta- analysis 
Methods Group recommendations19 28 and reported 
according to the Preferred Reporting Items for System-
atic Reviews and Meta- analyses of Individual Participant 
Data.20
Part I: systematic review to identify eligible trials
Information sources
Four electronic bibliographic databases: Medical Litera-
ture Analysis and Retrieval System Online (MEDLINE) 
via Ovid, Excerpta Medica Database (Embase) via Ovid, 
Cumulative Index to Nursing and Allied Health Litera-
ture (CINAHL) Complete via EBSCOhost and Cochrane 
Central Register of Controlled Trials (CENTRAL) via 
the Cochrane Library were searched from inception to 
28 September 2019. Reference lists of eligible studies 
and relevant systematic reviews were cross- checked and 
eligible trial principal investigators consulted regarding 
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1 critical illness/ or critical care/ or intensive care unit/ Subject 
headings
2 ((intensive adj care) or (critical adj care) or (intensive adj care adj unit*) or (critically adj ill) or (critical 
adj illness) or ICU).mp.(mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word, candidate 
term word)
Keywords
3 1 or 2   
Tier 2: Intervention
4 Rehabilitation/ or Exercise/ or Resistance Training/ or “PHYSICAL AND REHABILITATION MEDICINE”/ 
OR EXERCISE THERAPY/ or Physical Therapy Modalities/ or Early Ambulation/
Subject 
headings
5 (mobilisation or mobilization or physiotherapy or (physical adj therapy) or exercise or (exercise adj 
training) or (strength adj training) or (resistance adj training) or (exercise adj therapy) or rehabilitation 
or (physical adj rehabilitation) or (exercise adj therapy) or (rehabilitation adj medicine)).mp.(mp=title, 
abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword, floating subheading word, candidate term word)
Keywords
6 4 or 5   
Tier 3: Study Design
7 Randomized Controlled Trial/ Subject 
headings
8 ((randomised adj controlled adj trial) or (randomized adj controlled adj trial) or (randomised adj clinical 
adj trial) or (randomized adj clinical adj trial) or RCT).mp.(mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading word, candidate term word)
Keywords
9 7 or 8   
10 3 and 6 and 9   
additional potentially relevant studies. No date or 
language restrictions were applied to the search.
Search strategy
A three- tier search strategy was performed using both 
subject headings and keywords according to: (1) popula-
tion, (2) intervention and (3) study design. Population: 
intensive care OR critical care OR critical care outcomes 
OR critical illness OR ICU OR critically ill. Intervention: 
physical rehabilitation OR strength training OR exercise 
therapy OR physical therapy. Study design: randomised 
controlled trial OR randomised clinical trial. The search 
strategy for MEDLINE is shown in table 1.
Selection process
The study selection process is summarised in figure 1. 
One reviewer (JRAJ) designed the search, screened titles 
of retrieved articles and removed duplicate and non- 
relevant references. The remaining titles and abstracts 
were screened independently and in duplicate by two 
reviewers (JRAJ and LAM) according to the eligibility 
criteria (see below). When there was insufficient informa-
tion to determine whether a study was eligible, the full 
text was obtained and reviewed. Full texts were reviewed 
independently and in duplicate by two reviewers (JRAJ 
and LAM) to assess for eligibility. Disagreements between 
the two independent reviewers (JRAJ and LAM) were 
resolved through discussion and did not require consul-
tation with a third independent reviewer. Records were 
managed in EndNote X9. From 2178 records, four 
randomised controlled trials7–10 were deemed eligible for 
the individual participant data meta- analysis.
Eligibility criteria
Eligibility criteria were applied at trial level and are listed 
below according to population, study design, interven-
tion, comparator, outcomes, participant characteristics 
and publication type.
Population
Adults aged 18 years and older admitted to ICU.
Study design
Randomised controlled trials with more than 50 partic-
ipants were included. The sample size criterion was 
incorporated as a pragmatic approach to study selection, 
whereby larger randomised controlled trials were priori-
tised to improve feasibility of individual participant data 
acquisition.
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Figure 1 Trial selection process. CENTRAL, Cochrane 
Central Register of Controlled Trials; CINAHL, Cumulative 
Index to Nursing and Allied Health Literature; EMBASE, 
Excerpta Medica Database; MEDLINE, Medical Literature 
Analysis and Retrieval System Online.
Intervention
The intervention group received additional physical 
rehabilitation that included exercise training (strength 
or endurance) or functional retraining during the acute 
hospital stay (ICU and/or acute hospital ward). Trials 
that examined the effectiveness of neuromuscular elec-
trical stimulation, respiratory management or inspiratory 
muscle training alone were excluded.
Comparator
Comparison with a control group that received standard 
physiotherapy or physical therapy care.
Outcomes
Minimum follow- up period of 3 months measuring 
both performance- based physical function and HRQoL 
outcomes.
Participant characteristics
Recorded participant chronic disease burden in sufficient 
detail to permit scoring with the Functional Comorbidity 
Index.29
Publication type
Randomised controlled trials published in full in a peer- 
reviewed journal were eligible. Research letters, trial 
protocols and conference abstracts were excluded. While 
no language restrictions were applied to the electronic 
bibliographic searches, records retrieved that were not 
published in English were excluded during the study 
selection process.
Risk of bias assessment
The revised Cochrane risk- of- bias tool for randomised 
trials30 will be used. Two reviewers (JRAJ and LAM) will 
conduct the risk of bias assessment independently. If 
discrepancies in the risk of bias assessment by the two 
reviewers (JRAJ and LAM) cannot be resolved by discus-
sion, verification will be sought from the relevant trial 
principal investigators, and a third independent reviewer 
(LD) will make the final decision. Published data will be 
used to inform the risk of bias assessment; however, indi-
vidual participant data will be checked for key potential 
biases, including balance of baseline participant charac-
teristics by treatment group.
Part II: collection, checking and harmonisation of individual 
participant data
Data collection
Principal investigators of identified eligible trials7–10 have 
been invited to contribute individual participant data to 
the study and join the CRITICALConnect collaboration. 
Data sharing agreements are in place. Anonymised data 
sets will be accepted in any form, provided variables and 
categories are clearly labelled. Individual participant data 
that will be obtained are listed below according to partici-
pant characteristics, intervention and outcomes.
Participant characteristics
Chronic disease burden assessed with the Functional 
Comorbidity Index,29 age, sex and acute illness severity 
measured with the Acute Physiology, Age, Chronic Health 
Evaluation II score.31
Intervention
Number of physical rehabilitation intervention sessions.
Outcomes
A core outcome measurement set has been developed for 
research with acute respiratory failure survivors, where 
the 36- Item Short Form Health Survey version 2 is recom-
mended to comprehensively assess satisfaction with life 
and personal enjoyment.32 For assessment of HRQoL, we 
will accept version 1 and 2 of the 36- Item and 12- Item Short 
Form Health Surveys to ensure maximum inclusivity of 
trials. Consensus could not be reached on which physical 
function measures to include in the core outcome set,32 
we will collect information on all performance- based 
measures of physical function, but we will only analyse 
the measure that is most prevalent across the individual 
studies. Utilisation of healthcare resources measured 
according to mechanical ventilation duration (days), ICU 
length of stay (days), hospital length of stay (days) and 
discharge location (home, rehabilitation facility, another 
hospital, skilled nursing or aged care facility, other) will 
also be requested.
There are no published recommendations on standard 
time points for performance- based measures of physical 
function and HRQoL outcomes for rehabilitation trials 
with critically ill patients. Therefore, performance- based 
physical function at hospital discharge, 3 and 6 months, 
and HRQoL at 3, 6 and 12 months were considered to be 
of greatest importance to clinicians, researchers, patients 
and their families. Participant- reported outcomes of 
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HRQoL can involve retrospective consideration, specifi-
cally, the Short Form Health Surveys include questions 
pertaining to work, social and regular daily activities in 
the past 4 weeks making application in hospitalised criti-
cally ill patients difficult, therefore, the hospital discharge 
time point was considered not appropriate.
Data checking
We will use standard checks to identify missing or dupli-
cate data. Where data are missing, we will verify with the 
trial investigators that the data are in fact missing. Data 
validity and consistency will be assessed with range checks 
on variables supplied and checking the distribution of 
relevant baseline participant characteristics and number 
of participants against published records. To assess rando-
misation integrity, we will check for balance of key base-
line participant characteristics by treatment group. Any 
data queries will be verified by the trial investigators or 
appropriate research personnel.
Data harmonisation
To ensure accurate pooling of data, data sets will be 
converted to a common format and variables renamed 
for consistency. The individual trial data sets will then be 
combined to form the master data set with a variable to 
indicate the data corresponding to the original trial.
Part III: statistical analyses
We will describe trial- level and participant- level character-
istics of included studies. For all meta- analytic models, we 
will use a one- stage approach (ie, a generalised multi- level 
model) to synthesise the data from multiple trials, which 
fully accounts for the heterogeneity across the studies.33 34 
The multi- level models will allow for clustering between 
studies.35 We will present the proportions of missing data 
for the variables of interest by study. Next, we will use 
multiple imputation with 20 imputed data sets obtained 
using chained equations to account for the missing 
data.36 Mortality will occur throughout each of the trials. 
However, based on the previous research,6 we will assume 
that the interventions are not associated with mortality 
and that a ‘survivors only’ analysis is valid.37 Addition-
ally, it is widely accepted and concordant with common 
sense that it is not appropriate to impute for death when 
participant- reported outcomes, for example HRQoL, are 
used.38 Analyses will therefore be conducted with subjects 
retained in their original assigned groups, which means 
that the analyses will be modified intention to treat; no 
missing values due to mortality will be imputed, and 
deaths prior to an analysis time point will be omitted from 
analysis at that time point.
Objective 1
We will use longitudinal models to assess the effect of 
physical rehabilitation according to performance- based 
physical function outcomes at hospital discharge, 3 and 
6 months, and HRQoL outcomes at 3, 6 and 12 months. 
We will fit models with separate interaction terms to assess 
whether the effects are modified by the following patient 
characteristics that were selected a priori:
1. Participants with low chronic disease burden 
(Functional Comorbidity Index score ≤1) versus those 
who are multimorbid (Functional Comorbidity Index 
score ≥2).
2. Age ranges of published disability risk groups for 
survivors of critical illness: young (≤45 years), older 
(>45 and<66 years) and oldest (≥66 years).39
3. Male versus female sex.
4. Acute illness severity according to Acute Physiology, 
Age, Chronic Health Evaluation II score based on ter-
tiles of the sample distribution.
Objective 2
The individual participant data will also be analysed to 
compare between group differences (intervention and 
control) for the utilisation of healthcare resources for the 
subgroups of objective one. A priori healthcare utilisation 
variables include mechanical ventilation duration (days), 
ICU length of stay (days), hospital length of stay (days) 
and discharge location (home, rehabilitation facility, 
another hospital, skilled nursing or aged care facility, 
other). Models will be fitted as described by Debray et al.33
Sensitivity analyses
We will undertake the following sensitivity analyses in 
order to assess the robustness of our results. We will use 
a two- stage approach to synthesise the complete data 
from multiple trials. In this approach, the data are first 
analysed separately for each trial (ie, the first stage) and 
then combined using a random effects model to obtain 
a pooled estimate (ie, the second stage). This will allow 
us to generate forest plots, investigate heterogeneity, visu-
alise differences across the above- mentioned subgroups. 
As only four trials will be included in this individual 
participant data meta- analysis, we will not be able to 
examine small study effects.40 41 We will also repeat the 
one- stage analysis using complete case analysis to assess 
the robustness of the assumptions made using multiple 
imputation to handle the missing data. Finally, we will 
include only studies with a low risk of bias to assess the 
impact of studies of lower methodological quality on the 
findings. All statistical analyses will be undertaken using 
Stata version 15.1.42
Patient and public involvement
Patient and public involvement will not be sought for the 
design or conduct of the study or dissemination of the 
results.
EthICs And dIssEMInAtIOn
This study does not require ethical review as only anony-
mised data will be used and no new data will be collected.43 
Each of the eligible randomised controlled trial identi-
fied from the systematic literature review were granted 
approval from their respective institutional review boards 
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or research ethics committees, and informed consent was 
provided for all participants enrolled.7–10 Additionally, 
data sharing agreements are in place permitting contri-
bution of individual participant data by each of the iden-
tified eligible trials. The study findings will be submitted 
for presentation at national (Australia) and international 
conferences. Through the combined efforts of our inter-
national collaborative group, CRITICALConnect, the 
study findings will be presented to the wider critical care 
community. Additionally, the results of this study will 
be submitted for publication in a leading peer- reviewed 
journal for the field.
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